华安证券给予特宝生物买入评级，2022业绩超预期，四季度净利亮眼，多项催化未来三年持续受益

七印授权

4U152LO8D1Y5ZIS7WUC7G6YFTUH3LWS67AY9Z7YYO4MC18EQSW

2023-01-26 04:07:45

article

071EBB10711C6F82544167B3D61425E16DD67EAE4F46B38FEAD691F520D63004

zh-CN

4923CFCD2C90249044AAB7420DC1644D9EAE543A

13998406

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

9ad2b34b91de83aab76ff90a049cc181061b3487b349cde89c9ef47798c8eaef4c3f66959200838a85e63b762e1c362912067013349af6d37204d144b3e195a81c

{"parameters":{"adaptation":"n","price":"100000"},"type":"cm"}

yuanben_63d1fc91877594.72315200

原本认证

https://www.yuanben.io/article/dde025c7-b14b-4d9c-abab-8de010267c49

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}